607
Participants
Start Date
February 8, 2013
Primary Completion Date
March 23, 2015
Study Completion Date
March 23, 2015
Linagliptin
tablet
Empagliflozin + Linagliptin
Fixed dose combination.
Empagliflozin + Linagliptin
Fixed dose combination
Empagliflozin + Linagliptin
Fixed dose combination
Empagliflozin placebo + Linagliptin placebo
Matching Empagliflozin + Linagliptin low dose
Empagliflozin + Linagliptin
Fixed dose combination.
1275.9.01013 Boehringer Ingelheim Investigational Site, Gulf Shores
1275.9.01009 Boehringer Ingelheim Investigational Site, Norwalk
1275.9.01015 Boehringer Ingelheim Investigational Site, San Diego
1275.9.01017 Boehringer Ingelheim Investigational Site, San Diego
1275.9.01011 Boehringer Ingelheim Investigational Site, Northglenn
1275.9.01010 Boehringer Ingelheim Investigational Site, Coral Gables
1275.9.01004 Boehringer Ingelheim Investigational Site, Miami
1275.9.01006 Boehringer Ingelheim Investigational Site, Oldsmar
1275.9.01001 Boehringer Ingelheim Investigational Site, Palm Coast
1275.9.01027 Boehringer Ingelheim Investigational Site, Port Orange
1275.9.01029 Boehringer Ingelheim Investigational Site, Blue Ridge
1275.9.01003 Boehringer Ingelheim Investigational Site, Marietta
1275.9.01022 Boehringer Ingelheim Investigational Site, Savannah
1275.9.01031 Boehringer Ingelheim Investigational Site, Chicago
1275.9.01019 Boehringer Ingelheim Investigational Site, Methuen
1275.9.01024 Boehringer Ingelheim Investigational Site, Troy
1275.9.01023 Boehringer Ingelheim Investigational Site, St Louis
1275.9.01002 Boehringer Ingelheim Investigational Site, Omaha
1275.9.01007 Boehringer Ingelheim Investigational Site, Newington
1275.9.01016 Boehringer Ingelheim Investigational Site, Asheboro
1275.9.01025 Boehringer Ingelheim Investigational Site, Burlington
1275.9.01014 Boehringer Ingelheim Investigational Site, Shelby
1275.9.01028 Boehringer Ingelheim Investigational Site, Winston-Salem
1275.9.01018 Boehringer Ingelheim Investigational Site, Dayton
1275.9.01005 Boehringer Ingelheim Investigational Site, Corvallis
1275.9.01032 Boehringer Ingelheim Investigational Site, Corpus Christi
1275.9.01030 Boehringer Ingelheim Investigational Site, Houston
1275.9.01021 Boehringer Ingelheim Investigational Site, San Antonio
1275.9.61009 Boehringer Ingelheim Investigational Site, Liverpool
1275.9.61001 Boehringer Ingelheim Investigational Site, St Leonards
1275.9.61003 Boehringer Ingelheim Investigational Site, Carina Heights
1275.9.61002 Boehringer Ingelheim Investigational Site, Herston
1275.9.61006 Boehringer Ingelheim Investigational Site, Malvern
1275.9.61007 Boehringer Ingelheim Investigational Site, Nedlands
1275.9.55002 Boehringer Ingelheim Investigational Site, Brasília
1275.9.55005 Boehringer Ingelheim Investigational Site, Goiânia
1275.9.55001 Boehringer Ingelheim Investigational Site, São Paulo
1275.9.55003 Boehringer Ingelheim Investigational Site, São Paulo
1275.9.55004 Boehringer Ingelheim Investigational Site, São Paulo
1275.9.01101 Boehringer Ingelheim Investigational Site, Burnaby
1275.9.01103 Boehringer Ingelheim Investigational Site, Victoria
1275.9.01105 Boehringer Ingelheim Investigational Site, Cornwall
1275.9.01106 Boehringer Ingelheim Investigational Site, Hamilton
1275.9.01104 Boehringer Ingelheim Investigational Site, Toronto
1275.9.01102 Boehringer Ingelheim Investigational Site, Waterloo
1275.9.34008 Boehringer Ingelheim Investigational Site, Barcelona
1275.9.33006 Boehringer Ingelheim Investigational Site, Bourg-des-Comptes
1275.9.33008 Boehringer Ingelheim Investigational Site, Dessenheim
1275.9.33003 Boehringer Ingelheim Investigational Site, La Riche
1275.9.33012 Boehringer Ingelheim Investigational Site, Paris
1275.9.33002 Boehringer Ingelheim Investigational Site, Saint-Avertin
1275.9.33005 Boehringer Ingelheim Investigational Site, Savonnières
1275.9.33004 Boehringer Ingelheim Investigational Site, Tours
1275.9.64005 Boehringer Ingelheim Investigational Site, Auckland, New Zealand
1275.9.64006 Boehringer Ingelheim Investigational Site, Auckland, New Zealand
1275.9.64008 Boehringer Ingelheim Investigational Site, Birkenhead Auckland
1275.9.64007 Boehringer Ingelheim Investigational Site, Christchurch Central
1275.9.64004 Boehringer Ingelheim Investigational Site, Christchurch, New Zealand
1275.9.64002 Boehringer Ingelheim Investigational Site, Otahuhu Auckland
1275.9.64001 Boehringer Ingelheim Investigational Site, Takapuna Auckland
1275.9.64003 Boehringer Ingelheim Investigational Site, Tauranga, New Zealand
1275.9.47001 Boehringer Ingelheim Investigational Site, Bergen
1275.9.47002 Boehringer Ingelheim Investigational Site, Oslo
1275.9.47003 Boehringer Ingelheim Investigational Site, Oslo
1275.9.47007 Boehringer Ingelheim Investigational Site, Oslo
1275.9.47006 Boehringer Ingelheim Investigational Site, Svelvik
1275.9.82006 Boehringer Ingelheim Investigational Site, Daejeon
1275.9.82009 Boehringer Ingelheim Investigational Site, Deagu
1275.9.82002 Boehringer Ingelheim Investigational Site, Goyang
1275.9.82004 Boehringer Ingelheim Investigational Site, Seongnam
1275.9.82001 Boehringer Ingelheim Investigational Site, Seoul
1275.9.82005 Boehringer Ingelheim Investigational Site, Seoul
1275.9.82007 Boehringer Ingelheim Investigational Site, Seoul
1275.9.82008 Boehringer Ingelheim Investigational Site, Seoul
1275.9.82010 Boehringer Ingelheim Investigational Site, Seoul
1275.9.34011 Boehringer Ingelheim Investigational Site, A Coruña
1275.9.34009 Boehringer Ingelheim Investigational Site, Alicante
1275.9.34005 Boehringer Ingelheim Investigational Site, Badía Del Vallès - Barcelona
1275.9.34001 Boehringer Ingelheim Investigational Site, Barcelona
1275.9.34003 Boehringer Ingelheim Investigational Site, Barcelona
1275.9.34004 Boehringer Ingelheim Investigational Site, Barcelona
1275.9.34002 Boehringer Ingelheim Investigational Site, Seville
1275.9.34010 Boehringer Ingelheim Investigational Site, Valencia
1275.9.34006 Boehringer Ingelheim Investigational Site, Vic
1275.9.88606 Boehringer Ingelheim Investigational Site, Kaohsiung City
1275.9.88607 Boehringer Ingelheim Investigational Site, Kaohsiung City
1275.9.88602 Boehringer Ingelheim Investigational Site, New Taipei City
1275.9.88603 Boehringer Ingelheim Investigational Site, Taichung
1275.9.88604 Boehringer Ingelheim Investigational Site, Taichung
1275.9.88605 Boehringer Ingelheim Investigational Site, Tainan City
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Boehringer Ingelheim
INDUSTRY